7388 TR for Sale
Ready Stock 3710 Bioactive Peptide Powder, Strict QC Inspection, Fast Delivery For Overseas Purchasers
-
CAS No.:
2381089-83-2
-
Grade:
Pharmaceutical Grade
-
Content:
99.97%
-
Packaging:
10mg*10vials
Tirzepatide,Retatrutide,GHK-CU,KPV,MOTS-C,KLOW80,Cartalax,NAD+,Selank,Semax
375 Ready Stock Bioactive Peptide Powder, Strict QC Inspection, Fast Delivery For Overseas Purchasers
-
CAS No.:
2381089-83-2
-
Grade:
Pharmaceutical Grade
-
Content:
99.97%
-
Packaging:
5mg*10vials
Tirzepatide,Retatrutide,GHK-CU,KPV,MOTS-C,KLOW80,Cartalax,NAD+,Selank,Semax
Ready Stock TA10 Bioactive Peptide Powder, Strict QC Inspection, Fast Delivery For Overseas Purchasers
-
CAS No.:
2381089-83-2
-
Grade:
Pharmaceutical Grade
-
Content:
99.97%
-
Packaging:
10mg*10vials
Tirzepatide,Retatrutide,GHK-CU,KPV,MOTS-C,KLOW80,Cartalax,NAD+,Selank,Semax
CND10high-quality products | Fast and safe delivery | 99% high purity | Timely shipment | Wholesale price
-
Price:
$1.5-1.9/MT FOB
-
CAS No.:
2381089-83-2
-
Grade:
Pharmaceutical Grade
-
Content:
99%
-
Packaging:
5mg10vials
Tirzepatide,Retatrutide,GHK-CU,KPV,MOTS-C,KLOW80,Cartalax,NAD+,Selank,Semax
SK5 Direct supply from Selank SK5 factory. High standard, 99% high purity
-
CAS No.:
2381089-83-2
-
Grade:
Pharmaceutical Grade
-
Content:
99.97%
-
Packaging:
5mg*10vials/box
Tirzepatide,Retatrutide,GHK-CU,KPV,MOTS-C,KLOW80,Cartalax,NAD+,Selank,Semax
Products You May Be Interested in
CND5 high-quality products | Fast and safe delivery | 99% high purity | Timely shipment | Wholesale price
-
Price:
$2.1-2.5/MT FOB
-
CAS No.:
2381089-83-2
-
Grade:
Pharmaceutical Grade
-
Content:
99%
-
Packaging:
5mg10vials
Tirzepatide,Retatrutide,GHK-CU,KPV,MOTS-C,KLOW80,Cartalax,NAD+,Selank,Semax
IG1 Factory direct sale. 99% pure, high quality, fast and safe delivery, on time arrival
-
CAS No.:
2381089-83-2
-
Grade:
Pharmaceutical Grade
-
Content:
99.97%
-
Packaging:
1mg*10vials/box
Tirzepatide,Retatrutide,GHK-CU,KPV,MOTS-C,KLOW80,Cartalax,NAD+,Selank,Semax
5AD,weight loss product, factory direct sale, low price with high quality
-
Price:
$1.3-1.6/MT FOB
-
CAS No.:
2381089-83-2
-
Grade:
Pharmaceutical Grade
-
Content:
99%
-
Packaging:
5mg10vials
Tirzepatide,Retatrutide,GHK-CU,KPV,MOTS-C,KLOW80,Cartalax,NAD+,Selank,Semax
KS5 5 Factory direct sale. 99% pure, high quality, fast and safe delivery,low price
-
CAS No.:
910463-68-2
-
Grade:
Pharmaceutical Grade
-
Content:
99.97%
-
Packaging:
5mg*10vials/box
Tirzepatide,Retatrutide,GHK-CU,KPV,MOTS-C,KLOW80,Cartalax,NAD+,Selank,Semax
10AD, weight loss product, factory direct sale, low price with high quality
-
CAS No.:
2381089-83-2
-
Grade:
Pharmaceutical Grade
-
Content:
99%
-
Packaging:
10mg10vials
Tirzepatide,Retatrutide,GHK-CU,KPV,MOTS-C,KLOW80,Cartalax,NAD+,Selank,Semax
- Finding TR for sale in large quantity of choices all on www.echemi.com. The suppliers of 7388 TR on the search result are been verified by the accurate information of each one. Accurate information is the prerequisite of transaction. Buy TR with 70000+ customers on ECHEMI and make orders now.
- TR from ECHEMI are quality guaranteed. The pursuit of high quality requires all partners of ECHEMI to be screened, whether its certificate, qualification or scale. TR will reach global regulation and requirement of various regions. Customized services of TR will provided to customers on ECHEMI.
- We are providing better products and services of TR with fair price and reasonable deal. Registered member can enjoy more services of TR on with market price and insights, global news, trade data and so on. Efficient order options is the key for supply chain services we offer for you. Buyers are getting help to grow their business internationally on buying TR.
- •Cost-Driven Acrylonitrile Market Halts Decline and Stabilizes
- •In August, the domestic propylene oxide market showed an upward trend in price levels
- •Business Society’s Market Outlook for n-Butanol on September 4, 2026: Fluctuating Trend
- •September 4, 2026 DMF Market View in China: Relatively Strong
- •Business Society’s September 4, 2026 Melamine Market Outlook: Fluctuating Trend